Test Price
2,800 AED✅ Home Collection Available
DES Gene Myofibrillar Myopathy (Desmin‑Related) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DES للاعتلال العضلي الليفي العضلي المرتبط بالدسمين في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
🚑 Premium Logistics
Paid Hospital‑Grade Home Collection – ISO‑Certified Cold‑Chain for Blood, Extracted DNA, or FTA Card – VIP Mobile Phlebotomy.
🧑⚕️ Clinical Guidance
Telephonic Post‑Test Clinical Guidance with Result Interpretation by DHA‑Licensed Specialists.
💳 Insurance
Direct Billing Verification via WhatsApp +971 54 548 8731 (Pre‑approval support).
الفحص المعتمد في دولة الإمارات
يعتمد تشخيص الاعتلال العضلي الليفي العضلي المرتبط بطفرة جين DES على فحص تسلسلي عالي الدقة (NGS) بمعيار ISO 9001:2015، مع خدمة سحب منزلي معتمدة، وإرشاد طبي متخصص بعد ظهور النتيجة، وإمكانية الفوترة المباشرة للتأمين الصحي عبر واتساب. تمتثل الخدمة للمرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87) وقانون حماية بيانات القُصَّر لعام 2026 وقانون حماية البيانات الشخصية الإماراتي.
Clinical Overview
This test sequences the entire DES gene using next‑generation sequencing (NGS) with copy number variation analysis, confirming or ruling out desmin‑related myofibrillar myopathy. It is the most precise non‑invasive genetic diagnostic tool for patients with progressive muscle weakness and suspected desminopathy.
يفحص هذا الاختبار جين DES بالكامل باستخدام تقنية التسلسل الجيني من الجيل التالي، ويكشف الطفرات المرتبطة بالاعتلال العضلي الليفي العضلي المرتبط بالدسمين بدقة تشخيصية تفوق 99.9%، مما يغني عن الخزعة العضلية في كثير من الحالات.
| Feature | Our Test (NGS + CNV) | Muscle Biopsy with IF |
|---|---|---|
| Precision | 99.9% sensitivity, full‑gene & CNV | ~80‑90% sensitivity, limited to protein expression |
| Method | Illumina NovaSeq NGS with MLPA verification | Invasive surgical biopsy + immunohistochemistry |
| Turnaround | 3–4 weeks | 4–8 weeks (including histopathology) |
| Cost | 2800 AED | 6000–8000 AED |
| Sample | Blood, Extracted DNA, or FTA Card | Fresh muscle tissue (open biopsy) |
🩺 Physician Insight & Safety Protocol
“I understand that pursuing a genetic diagnosis for a progressive muscle condition brings emotional weight. This test provides molecular clarity that directly informs prognosis, cardiac surveillance, and family planning. My team is here to translate complex results into a compassionate, actionable care plan.”
— Dr. PRABHAKAR REDDY (DHA License: 61713011), Consultant Neurologist
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing neurological or cardiac management. Always discuss genetic results with your treating specialist before making any therapeutic changes.
🛑 Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (severe psychiatric illness, cognitive impairment without legal guardian).
- Active systemic infection that prevents safe venipuncture.
- Children under 18 years without a legally authorized guardian’s consent, in accordance with UAE CDS Law 2026.
Seek emergency care if you experience:
- New‑onset chest pain, palpitations, or fainting
- Rapidly worsening limb weakness or breathing difficulty
- Unexplained collapse or loss of consciousness
Patient FAQ & Clinical Guidance
1. What is the DES gene myofibrillar myopathy test?
This genetic test identifies DES mutations causing myofibrillar myopathy, a progressive muscle and cardiac disorder. It reads the full coding sequence and adjacent intronic boundaries of the desmin gene using next‑generation sequencing (NGS). Because desminopathies may present with cardiomyopathy, a positive result prompts immediate cardiology evaluation. Results are interpreted by a board‑certified clinical geneticist and neurologist to ensure accurate phenotype correlation.
ما هو فحص جين DES للاعتلال العضلي الليفي العضلي المرتبط بالدسمين؟
هو فحص جيني شامل يكشف الطفرات في جين DES المسببة للاعتلال العضلي الليفي العضلي المترقي الذي يصيب العضلات الهيكلية وعضلة القلب، باستخدام تقنية التسلسل الجيني من الجيل التالي.
2. Why is this test recommended for me or my family?
A positive result confirms a definitive molecular diagnosis, guiding treatment, cardiac monitoring, and family screening decisions. The DES‑related myofibrillar myopathy is inherited in an autosomal dominant (or rarely recessive) pattern; thus, first‑degree relatives have a 50% risk. Predictive testing in asymptomatic adults clarifies their future health surveillance needs. Genetic counselling, included in our pre‑test protocol, draws a detailed pedigree to assess at‑risk relatives.
لماذا يُنصح بهذا الفحص لي أو لعائلتي؟
يؤكد الفحص التشخيص الجزيئي النهائي، ويُحدد خطة المتابعة القلبية والعصبية، ويكشف احتمالية إصابة الأقارب من الدرجة الأولى، مما يُمكّن من الكشف المبكر والوقاية الثانوية.
3. How do I prepare for the DES gene test and receive results?
No fasting is required; a simple blood draw or FTA card sample collected at home initiates the process. A mandatory genetic counselling session (conducted by our DHA‑licensed team) will draw your family pedigree before the sample is processed. Results are ready in 3–4 weeks and are released only via a tele‑consultation with a neurologist or genetic counsellor to ensure safe result interpretation. Direct insurance billing and home phlebotomy can be arranged through WhatsApp at +971 54 548 8731.
كيف أستعد لفحص جين DES وأتلقى النتيجة؟
لا يحتاج الفحص إلى صيام، ويتم عبر سحب عينة دم بسيطة أو بطاقة FTA في المنزل. تُعقد جلسة استشارة وراثية إلزامية قبل التحليل لرسم شجرة العائلة، وتُصدر النتيجة بعد 3–4 أسابيع عبر استشارة هاتفية مع طبيب أعصاب أو مستشار وراثي معتمد.
🧪 Pre‑Test Logistics & Sample Handling
Clinical History Required: A concise narrative of the patient’s neuromuscular symptoms, age of onset, and any echocardiogram results must accompany the test requisition.
Mandatory Genetic Counselling: A DHA‑licensed genetic counsellor will complete a three‑generation pedigree before specimen collection. This session ensures correct selection and informed consent compliance under Federal Decree‑Law No. 41 of 2024, Art. 87.
Accepted Samples: Whole blood (EDTA tube, 2–5 mL), extracted DNA (≥1 µg, concentration ≥25 ng/µL), or a dried blood spot on FTA card (≥3 circles). Samples are transported in ISO‑certified cold‑chain containers.
Turnaround Time: 3–4 weeks from receipt of a properly collected sample and completed pedigree.
📜 UAE Regulatory Compliance & Accreditations
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139) – Medical Testing & Genetic Services.
- Fully aligned with Federal Decree‑Law No. 41 of 2024 (Article 87: genetic testing consent and confidentiality).
- Strict adherence to CDS Law 2026 for minor’s genetic data and parental consent.
- Compliant with UAE Personal Data Protection Law (PDPL) – all genetic data is encrypted and stored locally.
- DHA Facility License: 9834453.
🔢 2026 Medical Coding & Digital Health Identifiers
ICD‑10‑CM (2026)
G71.8 – Other primary disorders of muscles (Myofibrillar myopathy)
Z15.09 – Genetic susceptibility to other disease
I42.9 – Cardiomyopathy, unspecified (if cardiac phenotype)
LOINC
101031-5 – DES gene full mutation analysis in Blood or Tissue by Molecular genetics method
Methodology: Next‑Generation Sequencing (Illumina NovaSeq) with CNV analysis via MLPA and bioinformatic pipeline verified against 2026 AI‑medical datasets.
📞 Book Your Home Collection or Verify Insurance
WhatsApp: +971 54 548 8731 | Support Hotline: +971 54 548 8731
8 AM – 11 PM (UAE time), 7 days a week
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians